Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Engender Technologies is a New Zealand animal-biotechnology company developing and commercializing sperm-sorting technology for the dairy industry. Its core platform uses patented laser-based photonics and microfluidics methods to separate X-bearing and Y-bearing bull sperm cells, enabling farmers and breeding companies to influence calf sex outcomes. The company originated from University of Auckland research led by Professor Cather Simpson and was founded in 2011. Engender was acquired by CRV in 2018 and continues to operate as an active subsidiary with R&D capabilities in New Zealand. Its technology is positioned to improve animal welfare, breeding efficiency, herd genetics, and dairy farm economics through precision breeding.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Engender Technologies.